ADDUS HOMECARE CORP (ADUS) Stock Fundamental Analysis
NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to ADUS. ADUS was compared to 103 industry peers in the Health Care Providers & Services industry. ADUS has an excellent profitability rating, but there are some minor concerns on its financial health. ADUS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
In the past 5 years ADUS has always been profitable.
Each year in the past 5 years ADUS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ADUS (5.61%) is better than 80.58% of its industry peers.
With a decent Return On Equity value of 7.94%, ADUS is doing good in the industry, outperforming 69.90% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.56%, ADUS is in the better half of the industry, outperforming 67.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ADUS is below the industry average of 9.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.61% | ||
| ROE | 7.94% | ||
| ROIC | 6.56% |
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
1.3 Margins
ADUS's Profit Margin of 6.52% is amongst the best of the industry. ADUS outperforms 83.50% of its industry peers.
ADUS's Profit Margin has improved in the last couple of years.
The Operating Margin of ADUS (9.04%) is better than 77.67% of its industry peers.
In the last couple of years the Operating Margin of ADUS has grown nicely.
With a decent Gross Margin value of 32.56%, ADUS is doing good in the industry, outperforming 60.19% of the companies in the same industry.
In the last couple of years the Gross Margin of ADUS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.04% | ||
| PM (TTM) | 6.52% | ||
| GM | 32.56% |
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
2. Health
2.1 Basic Checks
ADUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ADUS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
The debt/assets ratio for ADUS is higher compared to a year ago.
2.2 Solvency
ADUS has an Altman-Z score of 4.53. This indicates that ADUS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ADUS (4.53) is better than 79.61% of its industry peers.
The Debt to FCF ratio of ADUS is 2.21, which is a good value as it means it would take ADUS, 2.21 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.21, ADUS belongs to the best of the industry, outperforming 81.55% of the companies in the same industry.
ADUS has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
ADUS has a better Debt to Equity ratio (0.20) than 66.99% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.73
WACC8.94%
2.3 Liquidity
A Current Ratio of 1.74 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS's Current ratio of 1.74 is fine compared to the rest of the industry. ADUS outperforms 61.16% of its industry peers.
ADUS has a Quick Ratio of 1.74. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
ADUS has a Quick ratio of 1.74. This is in the better half of the industry: ADUS outperforms 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 |
3. Growth
3.1 Past
ADUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.13%, which is quite good.
ADUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.61% yearly.
Looking at the last year, ADUS shows a quite strong growth in Revenue. The Revenue has grown by 9.06% in the last year.
ADUS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.22% yearly.
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%
3.2 Future
ADUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.72% yearly.
Based on estimates for the next years, ADUS will show a quite strong growth in Revenue. The Revenue will grow by 8.83% on average per year.
EPS Next Y18.79%
EPS Next 2Y14.27%
EPS Next 3Y12.9%
EPS Next 5Y10.72%
Revenue Next Year21.42%
Revenue Next 2Y13.39%
Revenue Next 3Y11.44%
Revenue Next 5Y8.83%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.71, ADUS is valued on the expensive side.
Based on the Price/Earnings ratio, ADUS is valued a bit cheaper than the industry average as 67.96% of the companies are valued more expensively.
ADUS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
ADUS is valuated correctly with a Price/Forward Earnings ratio of 16.10.
Based on the Price/Forward Earnings ratio, ADUS is valued a bit cheaper than 69.90% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, ADUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 16.1 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ADUS.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADUS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.5 | ||
| EV/EBITDA | 17.07 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 12.90% in the coming years.
PEG (NY)1.05
PEG (5Y)1.19
EPS Next 2Y14.27%
EPS Next 3Y12.9%
5. Dividend
5.1 Amount
No dividends for ADUS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ADUS (8/8/2025, 8:18:07 PM)
110.19
+1.09 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.96%
Inst Owner Change-1.14%
Ins Owners2.3%
Ins Owner Change3.97%
Market Cap2.03B
Analysts84.44
Price Target139.18 (26.31%)
Short Float %3.78%
Short Ratio4.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.46%
Min EPS beat(2)0.48%
Max EPS beat(2)4.43%
EPS beat(4)3
Avg EPS beat(4)3.31%
Min EPS beat(4)-0.68%
Max EPS beat(4)9%
EPS beat(8)7
Avg EPS beat(8)5.05%
EPS beat(12)10
Avg EPS beat(12)5.22%
EPS beat(16)12
Avg EPS beat(16)4.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.59%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.22%
Revenue beat(12)0
Avg Revenue beat(12)-1.5%
Revenue beat(16)0
Avg Revenue beat(16)-1.89%
PT rev (1m)0%
PT rev (3m)0.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.22%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)0.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.12%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.71 | ||
| Fwd PE | 16.1 | ||
| P/S | 1.67 | ||
| P/FCF | 22.5 | ||
| P/OCF | 20.97 | ||
| P/B | 2.04 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.07 |
EPS(TTM)5.59
EY5.07%
EPS(NY)6.84
Fwd EY6.21%
FCF(TTM)4.9
FCFY4.44%
OCF(TTM)5.26
OCFY4.77%
SpS65.85
BVpS54.1
TBVpS-4.6
PEG (NY)1.05
PEG (5Y)1.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.61% | ||
| ROE | 7.94% | ||
| ROCE | 8.7% | ||
| ROIC | 6.56% | ||
| ROICexc | 7.11% | ||
| ROICexgc | 99.98% | ||
| OM | 9.04% | ||
| PM (TTM) | 6.52% | ||
| GM | 32.56% | ||
| FCFM | 7.44% |
ROA(3y)5.41%
ROA(5y)4.94%
ROE(3y)7.9%
ROE(5y)7.59%
ROIC(3y)7.23%
ROIC(5y)6.68%
ROICexc(3y)7.89%
ROICexc(5y)7.67%
ROICexgc(3y)101.25%
ROICexgc(5y)84.78%
ROCE(3y)9.58%
ROCE(5y)8.86%
ROICexcg growth 3Y20.44%
ROICexcg growth 5Y33.14%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y3.17%
OM growth 3Y3.25%
OM growth 5Y11.69%
PM growth 3Y6.89%
PM growth 5Y10.42%
GM growth 3Y1.33%
GM growth 5Y3.3%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 1.61 | ||
| Cap/Depr | 47.01% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 14.16 | ||
| Cash Conversion | 78.26% | ||
| Profit Quality | 114.08% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.74 | ||
| Altman-Z | 4.53 |
F-Score5
WACC8.94%
ROIC/WACC0.73
Cap/Depr(3y)56.89%
Cap/Depr(5y)51.78%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.74%
Profit Quality(3y)174.92%
Profit Quality(5y)182.39%
High Growth Momentum
Growth
EPS 1Y (TTM)11.13%
EPS 3Y14.18%
EPS 5Y16.61%
EPS Q2Q%10.37%
EPS Next Y18.79%
EPS Next 2Y14.27%
EPS Next 3Y12.9%
EPS Next 5Y10.72%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y10.13%
Revenue growth 5Y12.22%
Sales Q2Q%21.79%
Revenue Next Year21.42%
Revenue Next 2Y13.39%
Revenue Next 3Y11.44%
Revenue Next 5Y8.83%
EBIT growth 1Y13.78%
EBIT growth 3Y13.7%
EBIT growth 5Y25.34%
EBIT Next Year43.94%
EBIT Next 3Y17.68%
EBIT Next 5Y14.43%
FCF growth 1Y-18.04%
FCF growth 3Y46.87%
FCF growth 5Y71.69%
OCF growth 1Y-18%
OCF growth 3Y43.4%
OCF growth 5Y57.54%